Search

everythinglearnresearchcommunity

for

Search:↓

High-dose vitamin A and E with zinc improved blood sugar control and insulin function in diabetics, but may cause hair loss.

DAVID syndrome is a condition with immune system and hormone deficiencies, needing early diagnosis to avoid serious complications.

Cold Atmospheric Microwave Plasma (CAMP) helps hair cells grow and could potentially treat hair loss.

Proper care and management are crucial for successful hair transplants and minimizing complications.

A pancreatic tumor caused high glucagon levels and symptoms, but treatment reduced glucagon and shrank liver tumors.

Repaglinide-loaded liponiosomal hybrids improve blood sugar control and insulin release better than regular Repaglinide.

Improved nutrition quickly healed the patient's skin lesions.

A young woman with skin issues and weight loss improved after treating her pancreatitis and using skin treatments.

A newborn with severe low blood sugar due to a genetic issue needed major surgery after standard treatments failed.

A cat with a rare pancreatic tumor and diabetes died despite treatment, showing similar symptoms to a human condition.

More research is needed to understand if GLP-1 agonists affect hair health.

Ac-GFFY-IGF peptide is a promising, safe, and effective treatment for hair loss, better than current options.

New pyridine compounds effectively inhibit GSK3, a diabetes treatment target.

Formyl-peptide receptor agonists could be new anti-inflammatory drugs.

Aleglitazar and its major metabolite are safe enough to proceed to Phase 3 clinical trials.

A new small peptide may help hair growth by activating a specific receptor and should be tested in humans.

Semaglutide is an effective weekly treatment for obesity, promoting weight loss and improving health, despite some side effects.

Ginsenoside compound K shows promise for treating metabolic diseases like diabetes and obesity.

Certain peptides can prevent hair loss in young rats caused by a cancer drug.

Some drugs linked to growth hormones may increase the chance of hair loss in women.

The compound GD-23 may reduce anxiety like diazepam by targeting the TSPO receptor.

Targeting glucocorticoid action might help treat type-2 diabetes, but human trials are needed.

ASLAN004 was safe and well-tolerated, supporting further development for treating certain diseases.

The drug BAY 1158061 is safe, well-tolerated, and shows potential for treating diseases related to prolactin.

PPAR-γ helps control skin oil glands and inflammation, and its disruption can cause hair loss diseases.